Stocktoria
Lantheus Holdings, Inc. LNTH
Nasdaq · XNAS · stock · In Vitro & In Vivo Diagnostic Substances · website · IPO 2015-06-25
Lantheus Holdings, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 8,595,919 | $690.2M |
| Point72 Asset Management, L.P. | 979,310 | $74.3M |
| CITADEL ADVISORS LLC | 417,544 | $31.7M |
| MILLENNIUM MANAGEMENT LLC | 255,237 | $19.4M |
| AQR CAPITAL MANAGEMENT LLC | 115,572 | $8.5M |
| RENAISSANCE TECHNOLOGIES LLC | 77,182 | $5.9M |
| Bridgewater Associates, LP | 43,720 | $3.3M |
Source: SEC EDGAR filings · CIK 0001521036 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.